Introduction
Blood compatibility of synthetic nanomaterials is an essential 15 prerequisite for their use in drug delivery, 1,2 gene therapy, [3] [4] [5] and bioimaging. 6, 7 Previous studies have demonstrated that upon systemic administration, nanoparticles (NPs) can trigger series of biochemical reactions with major blood components, 8, 9 leading to blood coagulation 10, 11 and vascular thrombosis. 12 This activation 20 of the coagulation pathway can further result in multiple organ failure and death. 13 Upon contact with blood, NPs adsorb a wide variety of plasma proteins onto the surface that are closely associated with blood coagulation process. [14] [15] [16] In particular, blood coagulation factor 25 XII (FXII), a key zymogen of coagulation cascade, can initiate intrinsic coagulation pathway upon contact with foreign materials. 17, 18 Moreover, the denaturation of FXII can further increase the intrinsic coagulation process. 19 Previous reports have demonstrated that the denaturation of adsorbed proteins on NP 30 surfaces strongly depends on the curvature of NPs. 20, 21 However, the effect NP surface curvature on FXII and consequent intrinsic coagulation activity has not been to our knowledge investigated. Herein, we report the effect of nano-scale curvature on plasma coagulation activity using silica NPs of different sizes. In our 35 findings, the coagulation activity of silica NPs decreases with the decreasing NP size (higher curvature). This curvature-dependent coagulation activity was further confirmed by the interaction of NPs with FXII; a lower degree of denaturation/unfolding of FXII was observed for NPs with higher curvature, leading to little to no 40 plasma coagulation activity (Scheme 1). These results suggest that the interaction between FXII and NPs can be controlled by simply tuning the curvature of NPs and provide a means to either activate or inactivate intrinsic coagulation, independent of NP chemical composition. 
Results and discussions
Commercially available silica NPs were used to investigate the 55 size dependence of coagulation activity (see supporting information Table I and Figure S1 ). The in vitro intrinsic coagulation activity was measured by monitoring the amount of generated thrombin in human plasma by a modified activated partial thromboplastin time method (APTT). 22 Since intrinsic 60 coagulation activity correlates with the effective surface area of pro-coagulants, 23 we investigated NP coagulation activity at four different surface areas ( Figure 1 ). Flat glass was chosen as a positive control because of its strong pro-coagulant activity 24 and as a representative of SiO 2 surface with least surface curvature. To establish a clear relation between NP surface curvature and 15 intrinsic coagulation activity, we further performed experiments at a constant surface area and at a fixed time (3 hr). As anticipated, the intrinsic coagulation activity of silica NPs increased with increasing NP size (Figure 2a and Figure S2 ), demonstrating clear surface curvature-dependent coagulation 20 activity. We further investigated the dose-dependent coagulation activity of silica NPs of different sizes. As observed in Figure  2b , each NP showed a threshold concentration for the intrinsic coagulation activity, indicating that critical quantities of procoagulants are required to start intrinsic blood coagulation 25 pathway. The threshold concentration shifts to higher values for smaller NPs, suggesting the smaller NPs generated less thrombin at a constant concentration and incubation time. In other words, NPs of lower curvature are more coagulation active compared to higher curvature ones at same concentration. It also mirrors our 30 results in Figure 1a where flat glass (lowest curvature) is most active than all NPs. These results clearly demonstrate that at a given concentration, larger NPs are most active in initiating the intrinsic coagulation system, and that activity is reduced with increasing NP curvature.
35
Previous studies have demonstrated that denatured FXII on material surface is 500 times more susceptible to proteolytic activation than its native form. 25 Given the fact that proteins absorbed on large NPs lose their native structure and function due to denaturation, 26 we hypothesized that the intrinsic blood demonstrated no significant alteration of CD spectra of FXII (vide supra). However, when surface area of 4 nm silica NPs was increased to 1 m 2 /ml, a red shift was observed at the negative minimum (Figure 3b) . Moreover, the CD spectrum change was enhanced with longer incubation time (1h) for this NP, 70 demonstrating that denaturation of FXII is facilitated by larger surface area of procoagulant as well as prolonged incubation time. These trends of FXII denaturation are similar with intrinsic coagulation activation indicated in Figure 1 , attesting to our hypothesis that structural change of FXII on NP surfaces leads to 75 intrinsic coagulation activity. Taken together, adsorption of FXII on NPs with high curvature leads to no denaturation, restricting proteolytic cleavage of FXII. In contrast, FXII adsorbs on low curvature NPs with significant denaturation, thereby becomes susceptible to proteolytic cleavage by other enzyme such as 80 kallikrein, leading to intrinsic coagulation.
Conclusions
In summary, we demonstrated that in vitro intrinsic coagulation 
Intrinsic coagulation activity:
The test solution consisted of 10 ml of 0.1 M Tris. HCl (pH = 7.4), 0.6 ml of 5 N NaCl aq., 0.4 ml of 0.5 M CaCl 2 aq., 0.5 ml of 1 mM phosphatidyl-L-serine aq., 0.4 ml of 5 mM S-2238 aq., and 0.5 ml of human plasma. The silica nanoparticle dispersion was added to the above solution and 35 the total volume was adjusted to 18 ml using Milli-Q water. 180 µl of test solution was loaded into MPC polymer coated 96 well plate and incubated at 37°C. Thrombin generation, determined by conversion of S-2238, was measured by the absorbance at 405 nm in a mircoplate reader (Spectramax M2, Molecular Devices).
40
CD Measurement: The CD spectra of FXII in presence of silica nanoparticles were measured using J-720 spectropolarimeter (Jasco) using a quartz cuvette with a 1 mm path length. 320 µl FXII solution (3.6 mg/ml) was diluted with 1.4 ml of 0.1 M Tris. HCl (pH = 7.4). Silica nanoparticle dispersion in Tris. HCl was 45 added, and then the total concentration of FXII was adjusted to 4.5 µM using 0.1 M Tris.HCl. CD measurement was done from 190 to 250 nm at a rate of 100 nm/min.
